Wednesday, Sept. 26, noon-1 p.m. ET
Watch the live webcast at ForumHSPH.org. Registration to watch the event online is not required.
We also will stream live on Facebook https://www.facebook.com/Forumhsph
An on-demand video will be posted afterwards on the event website. A searchable transcript will be posted there a few days after the event.
Americans pay more money – sometimes much more money – for prescriptions than consumers in many other wealthy countries. Why? The drivers are many and complicated. Pharmaceutical companies, employers, health care providers, patients, lawmakers, and pharmacy benefit managers all play a role. Calls to make prescriptions more affordable have prompted new efforts, including at the federal level. Last May, for example, President Trump introduced a plan intended to help reduce drug prices. This Forum event aims to demystify the prescription drug pricing process. Experts will weigh issues such as regulation, price negotiation and competitive market pressures, ultimately asking why prescription costs matter for public health.
EXPERT PARTICIPANTS
-
Leemore Dafny, Professor of Business Administration, Harvard Business School
-
Richard Frank, Professor of Health Economics in the Department of Health Care Policy, Harvard Medical School
-
Aaron Kesselheim, Associate Professor of Medicine, Harvard Medical School/Brigham and Women’s Hospital, and Director of the Program On Regulation, Therapeutics, And Law (PORTAL)
-
Steven Pearson, President of the Institute for Clinical and Economic Review
-
Moderator: Caroline Humer, Correspondent, Reuters
Spread the word:
Send our panelists questions in advance to theforum@hsph.harvard.edu. The Forum will accommodate as many questions as we can during a limited Q&A.
We’ll be conducting a live chat on The Forum’s U.S. Drug Prices website.
Tweet us @ForumHSPH #drugprices
Media contact: Todd Datz, tdatz@hsph.harvard.edu, 617-432-8077